Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175. Most new prescriptions for specialty oral anticancer ...
NP Theresa Stukus and NP Nelli Zafman discuss long-term management considerations for a patient with metastatic ...
The U.S. Food and Drug Administration (FDA) has expanded the approved indication for pirtobrutinib (Jaypirca) to include the ...
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton ...
Reverse thermal mitomycin gel now offers a chemoablative approach that provides prolonged mitomycin exposure to the bladder lining. The panel reviews results from the single-arm ENVISION trial, in ...
Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials. At the American Society for Radiation Oncology ...
Solid tumor history, cardiopulmonary symptom burden, and age-dependent chemo intensity predicted 30-day readmission or death after AML induction. In a retrospective study published in JCO Clinical ...
The University of Kansas Cancer Center The University of South Alabama, Mitchell Cancer Institute The University of Texas MD Anderson Cancer Center The Winthrop P. Rockefeller Cancer Institute at the ...
September marks Gynecologic Cancer Awareness Month, an annual observation focused on increasing public and clinical awareness of gynecologic malignancies, including ovarian, endometrial, cervical, ...
At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients. At the American Society for Radiation Oncology ...
An FDA advisory panel voted to approve GRAIL's Galleri multi-cancer early detection test for adults 50+. Read key oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results